Frontiers
US$ 28.01
glp 1 agonisten GLP-1 Agonists: A Comprehensive Overview GLP-1 receptor agonists for individualized
Description
2000;528(Pt 1):165176
Some of the well-known ones include: Ozempic (semaglutide): Approved in 2017 for type 2 diabetes, also commonly used off-label for weight management
Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study
doi: 10.1056/NEJMoa1008862 3 HolmanRRPaulSKBethelMAMatthewsDRNeilHA
The most important unknowns (cardiovascular safety, evidence on hard kidney outcomes, head-to-head tirals etc) all report between now and 2028
